BSPK (Bespoke Extracts) EBIT : $-1.08 Mil (TTM As of Sep. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Bespoke Extracts EBIT?

Bespoke Extracts's earnings before interest and taxes (EBIT) for the three months ended in Sep. 2024 was $-0.26 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Sep. 2024 was $-1.08 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Bespoke Extracts's annualized ROC % for the quarter that ended in Sep. 2024 was -247.17%. Bespoke Extracts's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was -518.81%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Bespoke Extracts's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2024 was -40.75%.

Bespoke Extracts EBIT Historical Data

The historical data trend for Bespoke Extracts's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bespoke Extracts EBIT Chart

Bespoke Extracts Annual Data

Trend

Aug14

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

2.94

-4.11

-0.97

-4.10

-1.47

Bespoke Extracts Quarterly Data
	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
EBIT	Get a 7-Day Free Trial															-0.30	-0.27	-0.30	-0.25	-0.26

Competitive Comparison of Bespoke Extracts's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Bespoke Extracts's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bespoke Extracts's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bespoke Extracts's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Bespoke Extracts's EV-to-EBIT falls into.

Bespoke Extracts EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.08 Mil.

Bespoke Extracts (OTCPK:BSPK) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Bespoke Extracts's annualized ROC % for the quarter that ended in Sep. 2024 is calculated as:

	ROC % (Q: Sep. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2024 )	+	Invested Capital (Q: Sep. 2024 ))	/ count )
=	-1.048 * ( 1 - 0% )	/	( (0.415	+	0.433)	/ 2 )
=	-1.048	/	0.424
=	-247.17 %

where

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.367	-	1.391	-	( 0.025	-	max(0, 1.573	-	0.134	+	0.025	))
=	0.415

	Invested Capital		(Q: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	0.338	-	1.509	-	( 0.021	-	max(0, 1.728	-	0.124	+	0.021	))
=	0.433

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Bespoke Extracts's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Sep. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2024		Q: Sep. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-1.048	/	( ( (0.212 + max(-1.282, 0))	+	(0.192 + max(-1.406, 0)) )	/	2 )
=	-1.048	/	( ( 0.212	+	0.192 )	/	2 )
=	-1.048	/	0.202
=	-518.81 %

where Working Capital is:

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.059	+	0.032	+	0.018)	-	(1.391	+	0	+	0)
=	-1.282

	Working Capital		(Q: Sep. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(0.046	+	0.044	+	0.013)	-	(1.509	+	0	+	0)
=	-1.406

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Sep. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Bespoke Extracts's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Sep. 2024 )
	=	-1.08	/	2.650
	=	-40.75 %

Bespoke Extracts EBIT Related Terms

Thank you for viewing the detailed overview of Bespoke Extracts's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Bespoke Extracts Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bespoke Extracts Inc (OTCPK:BSPK) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

12001 E. 33rd Avenue, Unit O, Aurora, Denver, CO, USA, 80010

Website

https://www.bespokeextracts.com

Bespoke Extracts Inc is focused on selling its proprietary line of specially-formulated, premium quality, hemp-derived CBD products. It unveiled a new brand image and a new line-up of seven hemp-derived CBD formulations available for purchase in the form of tinctures and softgels.

Executives

Michael Feinsod	director, 10 percent owner, officer: CEO
Tyler Hunter Garth	director, officer: President	6300 E HAMPDEN AVE, 2306, DENVER CO 80222
Danil Pollack	10 percent owner, officer: President and CEO	6 GAUGUIN AVE., VAUGHAN A6 L4J9J7
Niquana Monique Noel	10 percent owner, officer: President and CEO	1316 SW 3RD COURT, FT. LAUDERDALE FL 33312
Marc Yahr	director, 10 percent owner, officer: President and CEO	1966 NE 123RD STREET, NUM 170, NORTH MIAMI FL 33181
Anthony Ivankovich	10 percent owner	971 CRANDON BLVD., APT. PH-6, KEY BISCAYNE FL 33149
Mcglothlin Holdings, Ltd.	10 percent owner	402 W. DAVIS, LULING TX 78648
Barry Tenzer	director, 10 percent owner, officer: President, CEO, CFO	290 LENOX AVENUE, NEW YORK NY 10027
Roberto Fata	director, 10 percent owner, officer: Executive VP	290 LENOX AVENUE, SECOND FLOOR, NEW YORK NY 10027
Lyle Hauser	10 percent owner	290 LENOX AVENUE, SECOND FLOOR, NEW YORK NY 10027